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Abstract We assessed reliability of self-reported diag-
nostic radiation history in BRCA1/2 mutation carriers with
and without breast cancer. Within the frame-work of the
HEBON study, 401 BRCA1/2 mutation carriers completed
a baseline (1999–2004) and a follow-up questionnaire
(2006–2007). Test–retest reliability of self-reported expo-
sure to chest X-rays, fluoroscopies and mammograms was
assessed for the entire study population and by case status.
Overall proportion agreement on reporting ever/never
exposure was good ([ 75%), while the corresponding
kappa coefficients were between 0.40 and 0.75, indicating
at least moderate reliability beyond chance. Reliability of
number of exposures was also good ([ 75%). Proportion
agreement on reporting age at first mammogram was low
(40%) for exact consistency and moderate (60%) for con-
sistency ± 1 year. Reliability of age at first mammogram
was higher for cases than for unaffected carriers
(P \ 0.001) but this difference disappeared when exclud-
ing diagnostic mammograms (P = 0.60). In unaffected
carriers proportion agreement on age at last mammogram
was 50%. In general, the direction of disagreement on all
items was equally distributed. More consistent reporting
was mainly determined by a younger age at questionnaire
completion. In conclusion, inconsistent self-report of
diagnostic radiation by BRCA1/2 mutation carriers was
mainly non-differential by disease status.
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Abbreviations
BPM Bilateral prophylactic mastectomy
BPO Bilateral prophylactic (salpingo-)
oophorectomy
Carriers BRCA1/2 mutation carriers
CI Confidence interval
HEBON Hereditary Breast and Ovarian cancer
study the Netherlands
MRI Magnetic resonance imaging
NCR Netherlands Cancer Registry
OR Odds ratio
PALGA Netherlands Pathology Database
TB Tuberculosis
Introduction
Exposure to low dose ionizing (or: diagnostic) radiation
may increase the risk of breast cancer in the general pop-
ulation, especially when exposure occurred at young ages
[1, 2]. Because BRCA mutations are associated with a
reduction in DNA repair efficiency [3], it has been
hypothesized that BRCA1/2 mutation carriers might
experience greater risk of radiation-induced breast cancer.
In two recent studies, exposure to chest X-rays, especially
at young ages, was associated with an increased breast
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cancer risk among carriers [4, 5], but in two other studies
on exposure to mammograms no association was observed
[6, 7]. However, these results must be interpreted with
caution since the studies relied on self-reported diagnostic
radiation history and had a retrospective design (with
potential recall and/or survival bias). In the Netherlands,
carriers are currently recommended to start breast cancer
screening by MRI from age 25 and mammography from
age 30 onwards [8], but in the past carriers may have
started mammographic screening at younger ages [6, 7].
Both retrospective and prospective studies rely on self-
reports rather than medical record review because of the
time and cost constraints of medical record abstraction as
well as the difficulties in assessing diagnostic radiation
history from medical records, especially for exposures that
occurred during childhood or in the distant past [9]. It is
important to investigate the accuracy of self-reported
diagnostic radiation histories. In retrospective studies
inaccuracy may lead to non-differential and/or differential
misclassification which would affect the risk estimates in
an epidemiological study.
A number of studies on reliability [10–16] and validity
[9, 17–19] of self-reported diagnostic radiation exposure in
the general population have been conducted. Test–retest
reliability varies within the measure of self-reported
mammography [10–16] and consistency of reporting life-
time number of mammograms decreases with increasing
number of exposures [11, 12]. Differences in accuracy of
self-reported diagnostic radiation history between affected
and unaffected women were so far only investigated in a
few validation studies [17, 18, 20]. Although these studies
showed a certain amount of disagreement between self-
reports and medical records, there were no differences in
disagreement between cases and controls (non-differential
misclassification).
This is the first study investigating reliability of self-
reported diagnostic radiation exposure at young ages in
BRCA1/2 mutation carriers. Based on their positive family
history, associated cancer screens, and DNA testing in a
clinical setting, these women are probably more health
conscious than the general population, regardless of whe-
ther they had breast cancer or not. Furthermore, because of
their high-risk status, their exposure to diagnostic radiation
is relatively high since they are screened more intensively
from a relatively young age onwards.
Materials and methods
Study population
This study on reliability of self-reported diagnostic radia-
tion history among BRCA1/2 mutation carriers was con-
ducted within the framework of the HEBON study, of
which the design was described earlier [21]. In brief, the
HEBON study is an ongoing nationwide retrospective
cohort study with prospective follow-up among members
of BRCA1/2 families in the Netherlands. Female family
members were eligible if they (a) carried a BRCA1 or
BRCA2 mutation; (b) were alive and had no personal
history of breast and/or ovarian cancer on January 1, 1960,
or born after 1960; and (c) were at age 18 or older at study
entry. Figure 1 depicts the identification of the study
population for the present study. Between 1999 and 2004,
524 BRCA1/2 mutation carriers completed a baseline risk
factor questionnaire and were eligible for a follow-up
questionnaire in 2006–2007. Hundred carriers could not be
invited for the follow-up questionnaire, mainly because
they had died during follow-up period (7%) or indicated at
baseline that they did not want to be invited again (9%). Of
the 476 carriers (45% affected with breast cancer) invited
for the follow-up study, 401 responded (84%). Thirteen
carriers were diagnosed with a primary invasive breast
cancer in the period between baseline and follow-up. Since
Fig. 1 Identification of the
study population (N = 401)
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this event might have influenced reporting in the follow-up
questionnaire, and the number of incident cases was too
small for a subgroup analysis, we excluded them from the
analysis. Thus, information from 388 carriers (167 prevalent
breast cancer cases) was used for the reliability analysis.
Data collection
In the baseline questionnaire, assessment of diagnostic
radiation exposure was based on the following questions:
ever/never having had a chest X-ray before age 20, fluo-
roscopy for TB, and/or mammogram. For fluoroscopies and
mammograms the age at first exposure was asked (and for
mammograms also the age at last exposure). Number of
exposures was reported in categories (fluoroscopy for TB
and chest X-rays before age 20: 1–3, 4–6, 7–9, 10 or more;
mammograms before age 30: 1–2, 3–4, more than 4; life-
time number of mammograms: 1–4, 5–10, more than 10).
The follow-up questionnaire contained indication-based
questions on lifetime diagnostic and therapeutic radiation
exposure (fluoroscopies, chest X-rays, CT-scans, mammo-
grams, radiotherapy, and other radiographic procedures using
ionizing radiation like DXA scans). For fluoroscopies, chest
X-rays, and mammograms the age at first and last exposure
were reported, as well as the exact number of exposures before
age 20, between age 20 and 29, and between age 30 and 39. For
mammograms, the lifetime number was also asked in cate-
gories (1–3, 4–6, 7–9, 10 or more).
Informed consent was obtained from each subject.
Information on cancer history and prophylactic surgeries
was either collected through PALGA [22] and NCR until
August 2007 and/or self-reported for the period not covered
by the registries (\1989). Ninety-six percent of breast can-
cers diagnosed after 1988 were confirmed by PALGA/NCR.
Statistical analysis
Reliability was assessed by proportion agreement and
Cohen’s kappa coefficient (j), which accounts for the
effect of chance agreement. Reliability was considered
poor if j B 0.40, moderate if 0.40 C j B 0.75, and
excellent if j[ 0.75 [23]. We also investigated the
direction of disagreement, i.e. under- and/or overreporting
of exposure in one questionnaire versus the other.
cSelf-reported exposure to chest X-rays before age 20,
fluoroscopies before age 30, mammograms before age 30,
and mammograms lifetime was compared between the
baseline and the follow-up questionnaire in the entire study
population and in prevalent cases and unaffected carriers
separately. First, reliability of ever/never exposure was
assessed. Then, among women who reported to have been
exposed in both questionnaires, reliability of age at first
exposure (fluoroscopies before age 30, mammograms
before age 30, and mammograms lifetime) and number of
exposures (chest X-rays before age 20, fluoroscopies before
age 30, and mammograms before age 30) was assessed. In
the baseline questionnaire, number of exposures was
reported in categories, while in the follow-up questionnaire
the exact number was reported. We examined if the exact
number fitted the indicated category. For reliability anal-
ysis of mammogram exposure, we excluded 13 carriers
who had received their first mammogram after the baseline
questionnaire.
In affected carriers, lifetime exposure to diagnostic
radiation was for a large part due to their breast cancer
diagnosis. Such exposures are not taken into account in an
epidemiological study of diagnostic radiation exposure and
breast cancer risk. Therefore, we also assessed reliability of
prediagnostic mammograms by excluding all mammo-
grams that occurred in the year before breast cancer diag-
nosis and thereafter. For number of mammograms before
age 40 and age at last mammogram, the pre- and postdi-
agnostic period could not be distinguished. Therefore,
reliability of these measures was assessed in unaffected
carriers only. For the reliability analysis of age at last
mammogram, women who had their last mammogram (as
reported in follow-up questionnaire) after baseline ques-
tionnaire completion were excluded.
Multivariate logistic regression was used to find pre-
dictors of inconsistent self-reporting of diagnostic radiation
exposures. The dependent variable in this model was dis-
agreement (no/yes) with agreement as the reference cate-
gory. The following potential determinants were examined:
case status, age at questionnaire completion, number of
years between baseline and follow-up questionnaire com-
pletion, educational level, nulliparity, having had prophy-
lactic surgery (RRM and/or BPO), and menopausal status.
For disagreement on the age at first mammogram we also
examined the reason for the first mammogram, lifetime
number of mammograms, and length of recall (age at
questionnaire minus age at first mammogram).
Differences in proportion agreement and other discrete
variables between prevalent cases and unaffected carriers
were examined by Pearson’s v2 test. Differences in con-
tinuous variables were examined by Student’s t-test. Two-
sided P-values B 0.05 were considered statistically sig-
nificant. Missing values were excluded from reliability
analysis. All analyses were performed using STATA/SE
10.0 (StataCorp LP).
Results
The general characteristics of the study population are sum-
marized in Table 1. The age (mean ± standard deviation) at
baseline questionnaire completion was 43.9 ± 12.2 years.
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Prevalent cases were older at questionnaire completion than
unaffected carriers (48.5 ± 10.4 and 40.5 ± 12.4 years,
respectively; P \ 0.001) and they had a lower educational
level (P \ 0.05). Mean time between questionnaires was
5.4 ± 0.8 years, and there was no difference between cases
and unaffected carriers (P = 0.731) The current study popu-
lation did not differ substantially from the eligible group in
general characteristics like age, parity, oral contraceptive use,
and menopausal status (data not shown).
Tables 2 and 3 show the results of the reliability analysis
on reporting chest X-rays before age 20, and fluoroscopies
and mammograms before age 30. Overall proportions
agreement on ever/never chest X-rays exposure before age
20 and fluoroscopies and mammograms before age 30 were
79, 77 and 90%, respectively. Disagreement tended to
involve a change from ‘ever’ in the baseline questionnaire
to ‘never’ in the follow-up questionnaire rather than vice
versa for chest X-rays and fluoroscopies, but not for
mammograms. Prevalent cases had a significantly lower
agreement (of *10%) for ever/never fluoroscopy for TB
before age 30 than unaffected carriers (P = 0.043), while
there were no differences in the direction of disagreement
(P = 0.512). For all items on ever/never exposure the
kappa was moderate, except for ever/never chest X-rays
before age 20 in unaffected carriers where it was poor
(0.34). Agreement on age at first fluoroscopy exposure was
poor (43%) and kappa was just below moderate (0.39), and
this was similar for prevalent cases and unaffected carriers
(P = 0.637). The mean age at first fluoroscopy was
16.4 ± 5.3 years in the baseline and 16.0 ± 5.5 years in
the follow-up questionnaire, respectively; there were no
differences between prevalent cases and unaffected carriers
(P = 0.444 and P = 0.771 for baseline and follow-up
questionnaire comparison, respectively). Reliability of age
at first mammogram before age 30 was lower for unaf-
fected carriers than for prevalent cases (P = 0.030), but for
cases this analysis included diagnostic mammograms. For
consistency within 1 year, agreement improved to 81% and
the difference in agreement between prevalent cases and
unaffected disappeared (P = 0.375). For both age at first
fluoroscopy and age at first mammogram before age 30, the
direction of disagreement was equally distributed and not
different between prevalent cases and unaffected carriers
(P = 0.340 and P = 0.650, respectively). Agreement on
number of exposures for all three diagnostic procedures
was good ([70%) and no differences between prevalent
cases and unaffected carriers were found. However, for
number of chest X-rays and mammograms kappa was poor
(0.26 and 0.35), and for number of fluoroscopies kappa was
moderate (0.46). For number of fluoroscopies and mam-
mograms before age 30 kappa was higher in prevalent
cases than in unaffected carriers. For all items on number
of exposures, the direction of disagreement was equally
distributed and not different between prevalent cases and
unaffected carriers. The size of disagreement on number of
exposures was generally small, e.g. for all women who
disagreed on number of mammograms before age 30, the
difference in number was between 1 and 4 exposures
(Table 4).
Reliability of lifetime exposure to mammograms was
assessed for all mammograms lifetime (including diagnos-
tic) and for prediagnostic mammograms only, separately
(Table 5). Reliability of ever/never mammograms was
excellent, however, the categories were hardly discriminant.
Among women who reported to have ever had a mammo-
gram in both questionnaires, the mean age at first mammo-
gram was 35.4 ± 9.3 years in the baseline and 36.0 ±
9.6 years in the follow-up questionnaire, respectively (data
Table 1 Characteristics of the study population (N = 388)
Characteristic Total (N = 388) Prevalent cases (N = 167) Unaffected (N = 221)
N % N % N %
Nulliparous 100 26 38 23 62 28
Postmenopausal
At baseline questionnaire 248 64 140 84 108 49
At follow-up questionnaire 301 78 155 93 146 66
Ever BPM 203 52 89a 53 114 52
Ever BPO 260 67 130b 78 130 59
Educational levelc
Low 157 41 83 50 74 34
Medium 133 34 44 27 89 40
High 97 25 39 23 58 26
a All after breast cancer diagnosis
b 5/130 Before breast cancer diagnosis
c Low, primary school; medium, secondary school; high, college or university
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not shown). Reliability of age at first mammogram lifetime
was significantly poorer for unaffected carriers than for
prevalent cases (P \ 0.001). However, when diagnostic
mammograms were excluded, reliability of age at first
prediagnostic mammogram was poor in prevalent cases as
well, and no longer significantly different from unaffected
carriers (agreement 39% and kappa 0.36, P = 0.599). The
difference in age at first prediagnostic mammogram (age
reported in follow-up questionnaire minus age reported in
baseline questionnaire) for all women ranged from -11 to
Table 2 Comparison of self-reported exposure to chest X-rays before age 20 and fluoroscopies before age 30 between baseline and follow-up
questionnaire for the entire study population (N = 388) and for prevalent cases (N = 167) and unaffected carriers (N = 221) separately
Total (N = 388) Prevalent cases (N = 167) Unaffected (N = 221) P*
N % N % N %
Chest X-rays \20
Ever/never (baseline/follow-up)
Never/never 250 67 101 64 149 70 0.855
Never/ever 27 7 10 6 17 8
Ever/never 50 13 22 14 28 13
Ever/ever 45 12 25 16 20 9
Agreement (%) 79.3 79.8 79.0
Kappa 0.41 0.48 0.34
No. of exposuresa (baseline/follow-up)
1–3/1–3 28 65 15 65 13 65 0.692
1–3/[3 6 14 3 13 3 15
[3/1–3 5 12 3 13 2 10
[3/[3 4 9 2 9 2 10
Agreement (%) 74.4 73.9 75.0
Kappa 0.26 0.23 0.29
Fluoroscopy for TB \30
Ever/never (baseline/follow-up)
Never/never 185 48 58 38 127 61 0.043
Never/ever 12 4 8 5 4 2
Ever/never 71 20 35 23 36 17
Ever/ever 90 28 50 33 40 19
Agreement (%) 76.8 71.5 80.7
Kappa 0.52 0.45 0.54
Age at firsta
Equal 23 43 13 46 10 40 0.637
Baseline \ follow-up 13 25 8 29 5 20
Baseline [ follow-up 17 32 7 25 10 40
Agreement (%) 43.4 46.4 40.0
Kappa 0.39 0.42 0.35
No. of exposuresa,b (baseline/follow-up)
1–3/1–3 32 46 14 36 18 60 0.907
1–3/[3 9 13 4 10 5 17
[3/1–3 9 13 6 15 3 10
[3/[3 19 28 15 38 4 13
Agreement (%) 73.9 74.4 73.3
Kappa 0.46 0.49 0.32
* P-value of Pearson’s v2 test difference in proportion agreement between prevalent cases and unaffected carriers
a Reliability analysis in women who reported to ever have been exposed in both baseline and follow-up questionnaire. The numbers in the
categories of age at first exposure and number of exposures do not always add up to 100% of ever/ever group due to missing values
b The number of exposures before age 30 reported in baseline questionnaire was based on the reported lifetime number of exposures, assuming
that the majority had occurred before the age of 30
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?24 years (median -1 year; mean down 2.6 ± 2.1 years;
mean up 4.2 ± 4.7 years). In 53/147 (36%) carriers who
reported an inconsistent age at first prediagnostic mammo-
gram, the difference in age was only 1 year (43% of carriers
differed [2 years and 14% [5 years). For consistency
within 1 year, reliability of age at first prediagnostic mam-
mogram increased to moderate (59%) for both prevalent
cases and unaffected carriers (P = 0.767), and for all
mammograms reliability increased to moderate for unaf-
fected carriers and good for prevalent cases (P = 0.004).
The direction of disagreement on age at first mammogram
lifetime was equally distributed, although prevalent cases
reported more often a younger age at first (prediagnostic)
mammogram in the follow-up questionnaire than in the
baseline questionnaire; however, this was not significantly
different from unaffected carriers (P = 0.326).
Among unaffected carriers (data not shown), agreement
on number of mammograms before age 40 was good (81%)
and kappa was moderate (0.57). Agreement on age at last
mammogram before baseline was 50% and kappa was
moderate (0.48). For both items, there were no differences
in the direction of disagreement.
We examined determinants of inconsistent reporting of
age at first prediagnostic mammogram lifetime
Table 3 Comparison of self-reported mammograms before age 30 between baseline and follow-up questionnaire for the entire study population
(N = 388) and for prevalent cases (N = 167) and unaffected carriers (N = 221) separately
Total (N = 388) Prevalent cases (N = 167) Unaffected (N = 221) P*
N % N % N %
All mammograms before age 30
Ever/never (baseline/follow-up)
Never/never 251 67 132 80 119 59 0.368
Never/ever 13 4 7 4 6 3
Ever/never 24 7 7 4 17 8
Ever/ever 78 21 18a 11 60 30
Agreement (%) 89.9 91.5 88.6
Kappa 0.74 0.67 0.75
Age at firstb
Equal 39 53 13 76 26 46 0.030
Baseline \ follow-up 13 18 3 18 10 18
Baseline [ follow-up 21 29 1 6 20 36
Agreement (%) 53.4 76.5 46.4
Kappa 0.48 0.71 0.40
Agreement within 1 year (%) 80.8 88.2 78.6 0.375
No. of exposures—ever/ever groupb,c (baseline/follow-up)
1–2/1–2 9 20 6 38 3 11 0.617
1–2/[2 6 14 2 13 4 14
[2/1–2 7 16 2 13 5 18
[2/[2 22 50 6 38 16 57
Agreement (%) 70.5 75.0 67.9
Kappa 0.35 0.50 0.18
* P-value of Pearson’s v2 test difference in proportion agreement between prevalent cases and unaffected carriers
a Includes 13 women with breast cancer diagnosis before age 30
b Reliability analysis in women who reported to ever had a mammogram before age 30 in baseline and follow-up questionnaire. The numbers in
the categories of age at first mammogram and number of mammograms do not always add up to 100% of ever/ever group due to missing values
c Women who were \ 30 years at baseline questionnaire completion were excluded (N = 35)
Table 4 Comparison of self-reported number of mammograms
before age 30 between baseline and follow-up questionnaire (N = 49)
Follow-up questionnaire
1 2 3 4 5 6 7 8 9 10 [10 Missing Total
Baseline questionnaire
1–2 6 3 3 1 2 0 0 0 0 0 0 3 18
3–4 2 3 2 6 2 2 0 1 0 0 0 1 19
[4 0 2 3 0 0 1 0 1 1 0 3 0 11
Missing 0 0 1 0 0 0 0 0 0 0 0 0 1
Total 8 8 9 7 4 3 0 2 1 0 3 4 49
Bold values represent carriers who reported the same number of
mammograms in the baseline and the follow-up questionnaire
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Table 5 Comparison of self-reported mammograms lifetime between baseline and follow-up questionnaire for the entire study population
(N = 388) and for prevalent cases (N = 167) and unaffected carriers (N = 221) separately
Total (N = 388) Prevalent cases (N = 167) Unaffected (N = 221) P*
N % N % N %
All mammograms
Ever/never (baseline/follow-up)
Never/never 6 2 0 0 6 3 0.218
Never/ever 2 \1 2 1 0 0
Ever/never 2 \1 1 \1 1 \1
Ever/ever 365 97 164 98 201 97
Agreement (%) 98.9 98.2 99.5
Kappa 0.74 – 0.92
Age at firsta
Exact agreement
Equal 148 44 84 55 64 35 \0.001
Baseline \ follow-up 91 27 32 21 59 32
Baseline [ follow-up 96 29 36 24 60 33
Agreement (%) 44.2 55.3 35.0
Kappa 0.42 0.53 0.33
Age at firsta
Agreement within 1 year
Equal 219 65 112 74 107 58 0.004
Baseline \ follow-up 63 19 22 14 41 22
Baseline [ follow-up 53 16 18 12 35 19
Agreement (%) 65.4 73.7 58.5
Kappa 0.64 0.73 0.57
Prediagnostic mammograms
Ever/never (baseline/follow-up)
Never/never 95 26 89 57 6 3 \0.001
Never/ever 6 2 6 4 0 0
Ever/never 15 4 14 9 1 \1
Ever/ever 247 68 46 30 201 96
Agreement (%) 94.2 87.1 99.5
Kappa 0.86 0.72 0.92
Age at firsta
Exact agreement
Equal 82 36 18 39 64 35 0.599
Baseline \ follow-up 70 31 11 24 59 32
Baseline [ follow-up 77 33 17 37 60 33
Agreement (%) 35.8 39.1 35.0
Kappa 0.34 0.36 0.33
Age at firsta
Agreement within 1 year
Equal 135 59 28 61 107 58 0.767
Baseline \ follow-up 48 21 7 15 41 22
Baseline [ follow-up 46 20 11 24 35 19
Agreement (%) 59.0 60.9 58.5
Kappa 0.58 0.59 0.57
* P-value of Pearson’s v2 test difference in proportion agreement between prevalent cases and unaffected carriers
a Reliability analysis in women who reported to ever had a mammogram before age 30 in baseline and follow-up questionnaire. The numbers in the
categories of age at first mammograms do not always add up to 100% of ever/ever group due to missing values
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(consistency within 1 year) and ever/never exposure to
fluoroscopies before age 30 (Table 6). In univariate anal-
ysis, the chance of disagreement on age at first mammo-
gram was 4% higher per additional year of age at
questionnaire completion (OR 1.04, 95% CI 1.01–1.06),
higher for postmenopausal women (OR 1.71, 95% CI 1.00–
2.98) and lower when the reason for the first mammogram
was having complaints (OR 0.58, 95% CI 0.32–1.06).
Unexpectedly, increased time between questionnaires was
associated with lower chance of disagreement (OR 0.70,
95% CI 0.50–0.90). Disagreement on ever/never having
had a fluoroscopy before age 30 was determined by case
status and age at questionnaire completion. However, in the
multivariate model of both items, there were no significant
associations between any of the potential predictors and the
chance of disagreement, although age at questionnaire
completion remained a marginally significant determinant
of disagreement.
Discussion
To our knowledge, this is the first study on reliability of
self-reported diagnostic radiation exposure history in
BRCA1/2 carriers. Proportion agreement on reporting ever/
never exposure was good ([75%), while the corresponding
kappa coefficients were between 0.40 and 0.75, indicating
at least moderate reliability beyond chance. Reliability of
number of exposures was also good ([75%). Reliability of
reporting age at first mammogram was low (40%) for exact
consistency and moderate (60%) for consistency within
1 year. Reliability of age at first mammogram was higher
for cases than for unaffected carriers (P \ 0.001) but this
difference disappeared when excluding diagnostic mam-
mograms (P = 0.599). Reliability of exact reporting of age
at last mammogram was 50% in unaffected carriers. In
general, the direction of disagreement on all items was
equally distributed, i.e. there was as much underreporting as
overreporting of exposure in one questionnaire versus the
other. However, for chest X-rays before age 20 and fluo-
roscopies before age 30, disagreement tended to involve a
change from ‘ever’ in the baseline questionnaire to ‘never’
in the follow-up questionnaire for both cases and unaffected
carriers. Being an unaffected carrier and being younger at
questionnaire completion were associated with more con-
sistent reporting of ever/never exposure to fluoroscopy for
tuberculosis before age 30. For all other measures, agree-
ment was non-differential by disease status. More consis-
tent reporting of age at first mammogram was mainly
determined by younger age at questionnaire completion.
Previous reliability studies [10–16] on self-reported
diagnostic radiation history were all on mammography in
the setting of evaluation of screening programmes. Reli-
ability varied by measure of self-reported mammography:
agreement on ever/never having had a mammogram, life-
time number of mammograms, and date of most recent
mammogram was approximately 90% [10–16], 60% [11,
12, 16], and 35% [10, 12, 13, 15, 16], respectively. Our
Table 6 Estimated Odds Ratios (95% CI) for disagreement on age at first mammogram lifetime and ever/never exposure to fluoroscopies before
age 30
Potential determinants of disagreement Age at 1st mammogram lifetimea
N = 229
Ever/never exposure to fluoroscopies
before age 30
N = 358
Univariate OR
(95% CI)
Adjusted ORb
(95% CI)
Univariate OR
(95% CI)
Adjusted ORb
(95% CI)
Case status (unaffected vs. prevalent case) 1.10 (0.57–2.14) 1.44 (0.67–3.11) 0.60 (0.37–0.99) 0.52 (0.26–1.05)
Age at follow-up questionnaire (per year) 1.04 (1.01–1.06) 1.03 (0.98–1.08) 1.02 (1.00–1.04) 1.01 (0.97–1.04)
Time between questionnaires (per year) 0.70 (0.50–0.90) 0.76 (0.53–1.10) 0.92 (0.67–1.26) 0.95 (0.70–1.31)
Educational level (high vs. low) 0.88 (0.45–1.72) 1.16 (0.55–2.44) 0.96 (0.70–1.30) 1.04 (0.75–1.43)
Nulliparous (yes vs. no) 0.71 (0.37–1.37) 1.04 (0.50–2.19) 0.70 (0.39–1.25) 0.77 (0.40–1.48)
BPO (ever vs. never) 1.35 (0.76–2.40) 1.55 (0.75–3.21) 1.08 (0.64–1.82) 0.78 (0.42–1.46)
RRM (ever vs. never) 0.83 (0.49–1.41) 0.72 (0.35–1.50) 0.89 (0.52–1.53) 1.48 (0.71–3.06)
Menopausal status (post vs. pre) 1.73 (1.00–2.98) 0.82 (0.33–2.04) 1.57 (0.93–2.66) 1.23 (0.55–2.75)
Reason 1st mammogramc (complaints vs. screening) 0.58 (0.32–1.06) 0.70 (0.35–1.42) Not applicable Not applicable
Lifetime no. of mammogramsc ([7 vs. 1–6) 0.96 (0.56–1.64) 0.64 (0.30–1.38) Not applicable Not applicable
Length of recalld (per year) 1.01 (0.97–1.05) 0.99 (0.94–1.05) Not applicable Not applicable
a Prediagnostic mammograms; agreement within 1 year
b Obtained from multivariate logistic regression model, adjusted for all applicable variables listed in table
c As reported in the follow-up questionnaire
d Length of recall: age at follow-up questionnaire completion minus age at 1st mammogram reported in follow-up questionnaire
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results on reliability of mammograms are in line with these
studies, although we observed a somewhat higher propor-
tion agreement on number of mammograms. Since the
interval between questionnaires was longer than in the other
reliability studies (i.e. 5.4 years vs. 1 week to 2.6 years,
respectively), reliability could have been expected to be
lower in our study but this appeared not to be the case.
Another difference between our study and the other reli-
ability studies is that most of these studies used in-person
and/or telephone interviews [10, 11, 13–16] instead of self-
administered mailed questionnaires. Personal or telephone
interview may enhance memory but may also lead to over-
reporting compared to questionnaire methods [19].
It is generally assumed that cases recall past exposures
more accurately than controls. Self-report may also be
influenced by whether the respondents are selected from
the general population, or from a clinical setting, where
they may have become more familiar with medical pro-
cedures and may remember the exposures better due to
cues in a health care setting. We had expected that reli-
ability would be good and similar for prevalent cases and
unaffected carriers since our study population of BRCA1/2
carriers was tested in a clinical setting. Reliability of exact
age at first mammogram, which was not investigated in
previous studies, was therefore rather disappointing. When
including diagnostic mammograms for cases, as expected,
reliability of reporting age at first mammogram before age
30 and lifetime was higher in prevalent cases than in
unaffected carriers (P \ 0.001). However, the difference in
agreement on age at first mammogram before age 30 dis-
appeared for consistency within 1 year (P = 0.375). There
was no difference between cases and unaffected carriers in
reliability of reporting age at first prediagnostic mammo-
gram (P = 0.599 for exact agreement and P = 0.767 for
agreement within 1 year). Unaffected carriers, however,
reported more often a younger age at first exposure before
age 30 in the follow-up questionnaire than cases but this
was not statistically significant (P = 0.107 and P = 0.269
for mammogram and fluoroscopy, respectively). In the
multivariate models, age at questionnaire completion was
the only predictor of disagreement, although this finding
was marginally significant. Menopausal status and reason
for first mammogram did not predict consistent reporting.
In exploratory analysis we found that for a number of
women the large difference in age at first mammogram was
due to the fact that on one questionnaire women had
reported their first screening mammography as being the
first mammogram ever made, while in the other they had
remembered a single mammogram which was made in the
more distant past because of complaints (e.g. when they
had felt a lump). This was independent of the direction of
disagreement. The reported age at start of screening was a
separate question in a different part of the follow-up
questionnaire and only completed when a woman under-
went screening at the time of questionnaire completion.
In contrast with other reliability studies [11, 12], we
found no evidence of an association between number of
mammograms and consistent reporting. Reliability of ever/
never exposure to chest X-rays before age 20 and fluo-
roscopies before age 30 was somewhat lower than for
mammograms, while reliability of number of exposures
was similar. Interestingly, reliability of ever/never expo-
sure to fluoroscopy for tuberculosis before age 30 was
significantly higher for unaffected carriers than for pre-
valent cases and this was not due to the difference in age at
questionnaire completion. Since we examined many dif-
ferences between cases and unaffected carriers, this may be
a chance finding. In general, our results cannot be directly
compared with those from validity studies [9, 17–19] that
compared self-reported information with medical records.
Differences between self-report and medical records may
be due to both systematic under- or over-reporting and lack
of reliability. Consistent underreporting by unaffected
carriers in both questionnaires can only be assessed in a
validation study. But validation of e.g. chest X-rays,
especially when occurred in the distant past, is extremely
difficult if not impossible because of the different locations,
destroyed records, and the fact that negative self-reports
can not be verified. Still, most validation studies suggest
that women tend to over-report the number of diagnostic
radiation exposures and underreport the time since their
last exposure (‘‘telescoping’’) [9, 18, 19]. We found no
evidence of telescoping on reliability; the direction of
disagreement on age at last mammogram was equally
distributed (data not shown).
Thirteen incident cases were excluded from the analysis.
In this group, we investigated reliability of ever/never chest
X-rays before age 20 (data not shown). Proportion agree-
ment and kappa were slightly higher than for the other
groups: 83 and 0.56%, respectively.
When interpreting these results, the strengths and limi-
tations of this study should be considered. This is the first
study investigating reliability of self-reported risk factor
exposure information in BRCA1/2 mutation carriers. Fur-
thermore, we were able to assess reliability of more than
one diagnostic radiation exposure type, to assess reliability
of age at first exposure, and to investigate differences in
reliability between affected and unaffected women. How-
ever, our study also has limitations. The most important
limitation concerns the differences between the baseline
and the follow-up questionnaire. For instance, general
versus indication-based questions and categorical answer
categories versus exact numbers for number of exposures.
We had expected that more exposures would be reported in
the indication-based follow-up questionnaire compared to
the baseline questionnaire. However, the amount of
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disagreement in both directions was similar for most
variables, whereas for chest X-rays and fluoroscopies we
observed a tendency of a change from ‘ever’ in the baseline
questionnaire to ‘never’ in the follow-up questionnaire
rather than vice versa. Also, for the analysis on number of
fluoroscopies before age 30, we based this number in the
baseline questionnaire on lifetime number of fluoroscopies
because there was no separate question on number of
exposures before age 30. Since in the Netherlands screen-
ing for tuberculosis by fluoroscopy was mainly done
through mass population screening between 1940 and 1960
in relatively young people [24,] we assumed that most of
the reported lifetime number of fluoroscopies had taken
place before age 30. Equal distribution of the direction of
disagreement suggested that this assumption was justified.
On the other hand, the differences between both ques-
tionnaires allowed us to improve the questionnaire for
future studies. For instance, the proportion of missing
values in age at first fluoroscopy for tuberculosis before age
30 was 36% in the baseline and 9% in the follow-up
questionnaire. Future studies measuring diagnostic radia-
tion by self-report may want to consider using an indica-
tion-based questionnaire where for example, for
mammogram exposure age at start screening should be
asked first, followed by a question on ever having had a
mammogram prior to the first screening mammogram. For
number of exposures the exact number may be asked
instead of categories, but in addition it should be possible
to give a range if one is not sure. Another limitation con-
cerns the use of Cohen’s kappa coefficient. If a population
is homogeneous with respect to the characteristic begin
studied, like in our study mammographic screening, j
becomes highly sensitive to small departures from perfect
concordance, [25] which explains the lower kappa for
several of the variables, even in presence of relatively high
proportion agreement.
Our findings indicate that consistency of self-reported
diagnostic radiation by BRCA1/2 mutation carriers was
mainly non-differential by disease status. These results add
to knowledge about the reliability of self-reported diag-
nostic radiation history and its effect on relative risks in
studies on the association between diagnostic radiation and
breast cancer; risks will likely be underestimated.
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